Filing Details
- Accession Number:
- 0001179110-10-016949
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-03 12:00:00
- Reporting Period:
- 2010-12-03
- Filing Date:
- 2010-12-03
- Accepted Time:
- 2010-12-03 19:16:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1318005 | W Michael Aguiar | Theravance, Inc. 901 Gateway Boulevard South San Francisco CA 94080 | Sr Vp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-12-03 | 10,000 | $26.51 | 109,601 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $26.42 to $26.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
